Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler-Toledo Presents Live Webinar on Ensuring USP Compliance

Published: Friday, November 29, 2013
Last Updated: Thursday, November 28, 2013
Bookmark and Share
Mr. Gregory Martin will explain the implications of the latest USP revisions for balance users.

Mettler-Toledo has announced an upcoming webinar entitled “Ensuring USP Compliance with Revised Chapters on Weighing" with special guest presenter Mr. Gregory Martin, President of Complectors Consulting LLC.

The United States Pharmacopeia (USP) revisions to General Chapters <41> Balances and <1251> Weighing on an Analytical Balance will become official on December 1, 2013.

This webinar will be hosted on Dec 3, 2013 at 08:00 PST, 11:00 EST, 16:00 GMT; 17:00 CET. Event registration is at: http://tinyurl.com/webinarusp.

In this free educational webinar, laboratory managers and professionals who are concerned with regulatory affairs, compliance and metrology will learn about the details of these latest changes, understand the impact on their weighing processes and gain advice on how to update their standard operating procedures (SOP's) to remain compliant.

General Chapter <41> now states that accurate weighing must be performed using a calibrated balance. Repeatability and accuracy requirements are clarified and updated, with new acceptance limits and permissible test weights.

General Chapter <1251> has undergone major revisions focusing on balance qualification and operation, including the importance of "minimum weight". A daily balance check, typical in the pharmaceutical industry, is not actually a requirement. Instead, the type and frequency of balance checks should be determined by the risk and process tolerance of the application. Performing the right tests at the right intervals will ensure quality results and can potentially save time and money by eliminating unnecessary testing!

General Chapter <1251> also introduces "gravimetric dosing", a weighing methodology for analytical standard and sample preparation. This method involves weighing of the sample and diluent, resulting in concentration units of mg/g.

During this webinar, Mr. Gregory Martin will explain the implications of the latest USP revisions for balance users. Weighing and compliance experts from Mettler-Toledo will advise on how standard operating procedures (SOP's) should be updated to ensure compliance.

This webinar provides a unique opportunity to obtain expert advice during a live question and answer session after the presentation, allowing verification that individual weighing processes are up-to-date in advance of the next audit.

The key learning objectives for webinar attendees are: to discover which tests have to be periodically performed on balances used for quantitative analysis and which acceptance criteria apply from 1st Dec, based on the USP revisions; to recognize that a daily balance check is not a requirement and get insight into the risk-based approach recommended by USP General Chapter <1251>; to learn how to assess and calculate the minimum weight of a balance; and to find out more about gravimetric sample preparation and how to implement this method.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!